title: [Testosterone replacement therapy for hypogonadism in men with prostate cancer].
abstract: Hypogonadism and prostate cancer (PCa) often coincide with increasing age. Recent reviews have found no evidence to suggest an increased risk of developing PCa with testosterone replacement therapy (TRT). The same lack of PCa risk is found in studies looking at men receiving TRT after radical prostatectomy for PCa. Reports on TRT in men on active surveillance are very few. In summary, current evidence does not support an association between TRT and an increased risk of PCa. Nevertheless, sufficiently powered trials with longer follow-up are warranted before making final conclusions.
authors.affiliation: fullejensen@gmail.com.
authors.forename: Christian F S
authors.initials: CF
authors.lastname: Jensen
authors.forename: Mikkel
authors.initials: M
authors.lastname: Fode
authors.forename: Peter
authors.initials: P
authors.lastname: Østergren
authors.forename: Jens
authors.initials: J
authors.lastname: Sønksen
mesh_terms: D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy; D008297:Male; D017410:Practice Guidelines as Topic; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000139:chemically induced* / Q000601:surgery; D012307:Risk Factors; D013739:Testosterone / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D013739:Testosterone